135 related articles for article (PubMed ID: 2006715)
41. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
[TBL] [Abstract][Full Text] [Related]
42. The importance of DNA flow cytometry in node-negative breast cancer.
Winchester DJ; Duda RB; August CZ; Goldschmidt RA; Wruck DM; Rademaker AW; Winchester DP; Merkel DE
Arch Surg; 1990 Jul; 125(7):886-9. PubMed ID: 2164372
[TBL] [Abstract][Full Text] [Related]
43. Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimens.
Bagwell CB; Clark GM; Spyratos F; Chassevent A; Bendahl PO; Stål O; Killander D; Jourdan ML; Romain S; Hunsberger B; Baldetorp B
Cytometry; 2001 Jun; 46(3):121-35. PubMed ID: 11449403
[TBL] [Abstract][Full Text] [Related]
44. DNA ploidy, S-phase fraction, and G2 fraction as prognostic determinants in human pancreatic cancer.
Eskelinen M; Lipponen P; Marin S; Haapasalo H; Mäkinen K; Puittinen J; Alhava E; Nordling S
Scand J Gastroenterol; 1992; 27(1):39-43. PubMed ID: 1736340
[TBL] [Abstract][Full Text] [Related]
45. S-phase fraction after gating on epithelial cells predicts recurrence in node-negative breast cancer.
Wingren S; Stål O; Sullivan S; Brisfors A; Nordenskjöld B
Int J Cancer; 1994 Oct; 59(1):7-10. PubMed ID: 7523314
[TBL] [Abstract][Full Text] [Related]
46. [Epithelial growth factor receptors (EGF-R) and DNA flow cytometry in addition to lymph node and hormone receptor status as prognostic factors in primary breast cancer].
Costa SD; Kaufmann M; Fabbro D; Tokus M; Feichter G; Klinga K; Bastert G
Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):375-8. PubMed ID: 2544476
[TBL] [Abstract][Full Text] [Related]
47. The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up.
Toikkanen S; Joensuu H; Klemi P
Br J Cancer; 1989 Nov; 60(5):693-700. PubMed ID: 2553094
[TBL] [Abstract][Full Text] [Related]
48. DNA ploidy and the percentage of cells in S-phase as prognostic factors for women with lymph node negative breast cancer.
Witzig TE; Ingle JN; Cha SS; Schaid DJ; Tabery RL; Wold LE; Grant C; Gonchoroff NJ; Katzmann JA
Cancer; 1994 Sep; 74(6):1752-61. PubMed ID: 8082078
[TBL] [Abstract][Full Text] [Related]
49. [Flow cytometry detected S-phase fraction and ploidy as prognostic parameters in primary, node-negative breast cancer].
Winter K; Eidtmann H; Jonat W
Geburtshilfe Frauenheilkd; 1994 May; 54(5):291-4. PubMed ID: 8050690
[TBL] [Abstract][Full Text] [Related]
50. The prognostic value of DNA ploidy and S-phase estimate in primary breast cancer: a prospective study.
Dieterich B; Albe X; Vassilakos P; Wieser S; Friedrich R; Krauer F
Int J Cancer; 1995 Sep; 63(1):49-54. PubMed ID: 7558451
[TBL] [Abstract][Full Text] [Related]
51. Flow cytometry and interactive image cytometry in endometrial carcinoma. A comparative and prognostic study.
Strang P; Stenkvist B; Bergström R; Stendahl U; Valdes del Campo M; Tribukait B
Anticancer Res; 1991; 11(2):783-8. PubMed ID: 2064334
[TBL] [Abstract][Full Text] [Related]
52. Deoxyribonucleic acid flow cytometric analysis of cervical adenocarcinoma: prognostic significance of deoxyribonucleic acid ploidy and S-phase fraction.
Leminen A; Paavonen J; Vesterinen E; Forss M; Wahlström T; Kulomaa P; Lehtinen M
Am J Obstet Gynecol; 1990 Mar; 162(3):848-53. PubMed ID: 2316596
[TBL] [Abstract][Full Text] [Related]
53. Relationship of DNA ploidy and S-phase fraction to survival after first recurrence of breast cancer.
Stål O; Carstensen JM; Wingren S; Rutqvist LE; Skoog L; Klintenberg C; Nordenskjöld B
Acta Oncol; 1994; 33(4):423-9. PubMed ID: 8018376
[TBL] [Abstract][Full Text] [Related]
54. Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma.
Russo A; Bazan V; Migliavacca M; Zanna I; Tubiolo C; Tumminello FM; Dardanoni G; Cajozzo M; Bazan P; Modica G; Latteri M; Tomasino RM; Colucci G; Gebbia N; Leto G
Clin Cancer Res; 2000 Jan; 6(1):178-84. PubMed ID: 10656448
[TBL] [Abstract][Full Text] [Related]
55. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast.
Friedman NS; Freedman MD
Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198
[TBL] [Abstract][Full Text] [Related]
56. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
Martin G; Halwani F; Shibata H; Meterissian S
Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
[TBL] [Abstract][Full Text] [Related]
57. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer.
Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y
Cancer; 1991 Nov; 68(9):1918-25. PubMed ID: 1655229
[TBL] [Abstract][Full Text] [Related]
58. Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer.
Stål O; Wingren S; Carstensen J; Rutqvist LE; Skoog L; Klintenberg C; Nordenskjöld B
Eur J Cancer Clin Oncol; 1989 Feb; 25(2):301-9. PubMed ID: 2702984
[TBL] [Abstract][Full Text] [Related]
59. The prognostic significance of ploidy analysis in operable breast cancer.
Sharma S; Mishra MC; Kapur BM; Verma K; Nath I
Cancer; 1991 Dec; 68(12):2612-6. PubMed ID: 1933810
[TBL] [Abstract][Full Text] [Related]
60. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.
Fisher B; Gunduz N; Costantino J; Fisher ER; Redmond C; Mamounas EP; Siderits R
Cancer; 1991 Oct; 68(7):1465-75. PubMed ID: 1893345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
